CS
VIVS

Credit Suisse’s VivoSim Labs VIVS Stock Holding History

Credit Suisse’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,301
Closed -$147K – 4577
2021
Q2 		$147K Buy
+1,301
New +$131K ﹤0.01% 4331
2019
Q3 		– Sell
-104
Closed -$13K – 4293
2019
Q2 		$13K Sell
104
-14
-12% -$2.65K ﹤0.01% 4055
2019
Q1 		$28K Buy
118
+35
+42% +$8.81K ﹤0.01% 3929
2018
Q4 		$19K Buy
+83
New +$20.9K ﹤0.01% 3837
2018
Q3 		– Sell
-113
Closed -$37K – 4035
2018
Q2 		$37K Sell
113
-48
-30% -$15.8K ﹤0.01% 3921
2018
Q1 		$39K Buy
161
+42
+35% +$12.3K ﹤0.01% 3900
2017
Q4 		$38K Sell
119
-427
-78% -$159K ﹤0.01% 3922
2017
Q3 		$291K Buy
546
+210
+63% +$112K ﹤0.01% 3757
2017
Q2 		$211K Sell
336
-43
-11% -$28.9K ﹤0.01% 3607
2017
Q1 		$289K Sell
379
-101
-21% -$80K ﹤0.01% 3524
2016
Q4 		$390K Buy
480
+11
+2% +$8.73K ﹤0.01% 3559
2016
Q3 		$427K Sell
469
-48
-9% -$47K ﹤0.01% 3499
2016
Q2 		$462K Buy
517
+119
+30% +$79.8K ﹤0.01% 3474
2016
Q1 		$208K Sell
398
-78
-16% -$39.6K ﹤0.01% 3669
2015
Q4 		$285K Buy
476
+122
+34% +$88.5K ﹤0.01% 3702
2015
Q3 		$227K Sell
354
-779
-69% -$592K ﹤0.01% 3869
2015
Q2 		$1.02M Buy
1,133
+695
+159% +$778K ﹤0.01% 3161
2015
Q1 		$371K Buy
438
+2
+0.5% +$2.76K ﹤0.01% 3737
2014
Q4 		$759K Buy
436
+157
+56% +$241K ﹤0.01% 3380
2014
Q3 		$426K Sell
279
-96
-26% -$174K ﹤0.01% 3745
2014
Q2 		$750K Sell
375
-268
-42% -$449K ﹤0.01% 3539
2014
Q1 		$1.18M Buy
643
+240
+60% +$557K ﹤0.01% 2978
2013
Q4 		$1.07M Buy
403
+89
+28% +$175K ﹤0.01% 3222
2013
Q3 		$435K Buy
+314
New +$438K ﹤0.01% 3579

Other funds holding VIVS

NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Credit Suisse's VIVS Position: Q3 2021 in Review

Credit Suisse sold out of VivoSim Labs (VIVS) in Q3 2021, closing a stake of 1,301 shares — an estimated $147K sold.

Credit Suisse first reported a position in VIVS in Q3 2013 and held it in 24 quarters. The position peaked at $1.18M in Q1 2014. 41 funds tracked by Wall St. Rank hold VIVS as of Q3 2021.

  • Credit Suisse reported no remaining VivoSim Labs position as of Q3 2021 after selling out during the quarter.
  • Credit Suisse sold 1,301 VivoSim Labs shares in Q3 2021, an estimated $147K.
  • Credit Suisse first reported a position in VivoSim Labs in Q3 2013 and held it in 24 quarters.
  • Credit Suisse's VivoSim Labs position peaked at $1.18M in Q1 2014.
  • 41 funds tracked by Wall St. Rank held VivoSim Labs as of Q3 2021.

Based on Credit Suisse's 13F filing for Q3 2021, filed 12 Nov 2021.